MARILYN MILLER: Open Payments
NPI 1649200585 · HUDSON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,410 in 80 payments from 24 companies in 2025. Trend: 2023 $1,609 · 2024 $1,714 · 2025 $1,410
Food & beverage: $1,410
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 18 | $192 |
| Amgen Inc. | 12 | $175 |
| Dexcom, Inc. | 7 | $130 |
| ABBVIE INC. | 4 | $127 |
| PFIZER INC. | 7 | $120 |
| Lundbeck LLC | 4 | $93 |
| Lilly USA, LLC | 3 | $62 |
| Exact Sciences Corporation | 2 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $47 |
Products named: TRELEGY ELLIPTA, Dexcom G6 Transmitter, EVENITY, ELIQUIS, REXULTI, UBRELVY, MOUNJARO, QULIPTA.
Industry payments across NY — which companies pay providers there.
